Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18064305 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Syndecan-1 a Surrogate Marker for IBD
Condition: Inflammatory Bowel Diseases
Interventions: Procedure: blood sample;   Procedure: Blood sample - venous blood 10 ml.

Study has passed its completion date and status has not been verified in more than two years.